Brandon Smith
Directeur des opérations chez PROTHENA CORPORATION PLC
Fortune : - $ au 30/04/2024
Postes actifs de Brandon Smith
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PROTHENA CORPORATION PLC | Directeur des opérations | 29/09/2021 | - |
| Corporate Officer/Principal | 03/03/2020 | 29/09/2021 |
Historique de carrière de Brandon Smith
Anciens postes connus de Brandon Smith
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Directeur des opérations | 01/01/2017 | 01/01/2020 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/06/2012 | 01/01/2017 |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/2012 | 01/01/2017 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2005 | 01/01/2012 |
Formation de Brandon Smith
| University of Michigan | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
| Irlande | 2 |
| 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Chief Operating Officer | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| AMGEN INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Brandon Smith
- Expérience